Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TOP1 | P11387 | 4/20 | 0.60 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.44 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.44 |
| ▸ | TERT | O14746 | 3/20 | 0.44 |
| ▸ | CYCS | P99999 | 3/20 | 0.42 |
| ▸ | ENPP2 | Q13822 | 1/20 | 0.41 |
| ▸ | ABCG2 | Q9UNQ0 | 1/20 | 0.39 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.39 |
| ▸ | NPC1 | O15118 | 1/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.39 |
| ▸ | LMNA | P02545 | 1/20 | 0.39 |
| ▸ | MAPT | P10636 | 1/20 | 0.39 |
| ▸ | TSHR | P16473 | 1/20 | 0.39 |
| ▸ | RAB9A | P51151 | 1/20 | 0.39 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.39 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.38 |
| ▸ | AKT1 | P31749 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9230080 | 1.00 | TOP1 (0.60) | TOP1CYP3A4CYP2D6TERTCYCS | |
| SCHEMBL10050511 | 0.94 | TOP1 (0.54) | TOP1CYP3A4CYP2D6TERTCYCS | |
| SCHEMBL14528653 | 0.86 | RAB9A (0.46) | TOP1NPC1MAPTRAB9A | |
| SCHEMBL10050507 | 0.81 | TERT (0.41) | TOP1TERTCYCSENPP2ABCG2 | |
| Pyridine SCHEMBL28010654 | 0.80 | CYP2D6 (0.49) | TOP1CYP3A4CYP2D6TERTCYCS | |
| SCHEMBL30968084 | 0.79 | TOP1 (0.84) | TOP1TERTCYCSENPP2ABCG2 | |
| SCHEMBL29961137 | 0.79 | TOP1 (0.78) | TOP1TERTCYCSENPP2ABCG2 | |
| SCHEMBL245937 | 0.79 | TOP1 (0.78) | TOP1TERTCYCSENPP2ABCG2 | |
| SCHEMBL10050486 | 0.79 | RAB9A (0.51) | TOP1NPC1MAPTRAB9A | |
| SCHEMBL28027946 | 0.79 | TOP1 (0.47) | TOP1TERTCYCSENPP2ABCG2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2346875-B1 | METALLOPORPHYRIN DERIVATIVES, NANOPARTICLES COMPRISING THE SAME, AND USE THEREOF FOR PHOTODYNAMIC THERAPY | CENTRE NAT RECH SCIENT (FR) | 2014-03-19 | — | — | EP | disclosed |
| EP-2346875-B1 | METALLOPORPHYRIN DERIVATIVES, NANOPARTICLES COMPRISING THE SAME, AND USE THEREOF FOR PHOTODYNAMIC THERAPY | CENTRE NAT RECH SCIENT (FR) | 2014-03-19 | — | — | EP | disclosed |
| US-8425879-B2 | Metalloporphyrin derivatives, nanoparticles comprising the same, and use thereof for photodynamic therapy | CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (FR) | 2013-04-23 | — | — | US | disclosed |
| US-8092661-B2 | Electropolymerisable monomers, soluble in an aqueous solution and comprising a metalloporphyrin | BIOMERIEUX (FR) | 2012-01-10 | — | — | US | disclosed |
| US-8092661-B2 | Electropolymerisable monomers, soluble in an aqueous solution and comprising a metalloporphyrin | BIOMERIEUX (FR) | 2012-01-10 | — | — | US | disclosed |
| US-20110262357-A1 | Metalloporphyrin Derivatives, Nanoparticles Comprising the Same, and Use Thereof for Photodynamic Therapy | CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (FR) | 2011-10-27 | — | — | US | disclosed |
| WO-2010029232-A1 | METALLOPORPHYRIN DERIVATIVES, NANOPARTICLES COMPRISING THE SAME, AND USE THEREOF FOR PHOTODYNAMIC THERAPY | CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (FR) | 2010-03-18 | — | — | WO | disclosed |
| US-20090314660-A1 | Novel Electropolymerisable Monomers, Soluble in an Aqueous Solution and Comprising a Metalloporphyrin | BIOMERIEUX (FR) | 2009-12-24 | — | — | US | disclosed |
| US-20090314660-A1 | Novel Electropolymerisable Monomers, Soluble in an Aqueous Solution and Comprising a Metalloporphyrin | BIOMERIEUX (FR) | 2009-12-24 | — | — | US | disclosed |
| WO-2007051947-A1 | NOVEL ELECTROPOLYMERISABLE MONOMERS WHICH ARE SOLUBLE IN AN AQUEOUS SOLUTION AND COMPRISE A METALLOPORPHYRINE | BIOMERIEUX (FR) | 2007-05-10 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110262357-A1 | Metalloporphyrin Derivatives, Nanoparticles Comprising the Same, and Use Thereof for Photodynamic Therapy | PPOX, PPIF, PPIL4 | TOP1 2238/4885CYP3A4 2867/4885CYP2D6 3931/4885 |
| US-20090314660-A1 | Novel Electropolymerisable Monomers, Soluble in an Aqueous Solution and Comprising a Metalloporphyrin | EPS15, PPOX, ACR | TOP1 4796/4885CYP3A4 503/4885CYP2D6 3253/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.